267 related articles for article (PubMed ID: 20847048)
1. Stable alpha-synuclein oligomers strongly inhibit chaperone activity of the Hsp70 system by weak interactions with J-domain co-chaperones.
Hinault MP; Cuendet AF; Mattoo RU; Mensi M; Dietler G; Lashuel HA; Goloubinoff P
J Biol Chem; 2010 Dec; 285(49):38173-82. PubMed ID: 20847048
[TBL] [Abstract][Full Text] [Related]
2. Identification of protein interfaces between α-synuclein, the principal component of Lewy bodies in Parkinson disease, and the molecular chaperones human Hsc70 and the yeast Ssa1p.
Redeker V; Pemberton S; Bienvenut W; Bousset L; Melki R
J Biol Chem; 2012 Sep; 287(39):32630-9. PubMed ID: 22843682
[TBL] [Abstract][Full Text] [Related]
3. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
4. DnaK/DnaJ/GrpE of Hsp70 system have differing effects on alpha-synuclein fibrillation involved in Parkinson's disease.
Ahmad A
Int J Biol Macromol; 2010 Mar; 46(2):275-9. PubMed ID: 20060408
[TBL] [Abstract][Full Text] [Related]
5. Specification of Hsp70 Function by Hsp40 Co-chaperones.
Cyr DM; Ramos CH
Subcell Biochem; 2023; 101():127-139. PubMed ID: 36520305
[TBL] [Abstract][Full Text] [Related]
6. HSP40 proteins use class-specific regulation to drive HSP70 functional diversity.
Faust O; Abayev-Avraham M; Wentink AS; Maurer M; Nillegoda NB; London N; Bukau B; Rosenzweig R
Nature; 2020 Nov; 587(7834):489-494. PubMed ID: 33177718
[TBL] [Abstract][Full Text] [Related]
7. Structural and Biochemical Properties of Hsp40/Hsp70 Chaperone System.
Faust O; Rosenzweig R
Adv Exp Med Biol; 2020; 1243():3-20. PubMed ID: 32297208
[TBL] [Abstract][Full Text] [Related]
8. Probing the different chaperone activities of the bacterial HSP70-HSP40 system using a thermolabile luciferase substrate.
Sharma SK; De Los Rios P; Goloubinoff P
Proteins; 2011 Jun; 79(6):1991-8. PubMed ID: 21488102
[TBL] [Abstract][Full Text] [Related]
9. Transient interactions of a slow-folding protein with the Hsp70 chaperone machinery.
Sekhar A; Santiago M; Lam HN; Lee JH; Cavagnero S
Protein Sci; 2012 Jul; 21(7):1042-55. PubMed ID: 22549943
[TBL] [Abstract][Full Text] [Related]
10. The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes.
Chien V; Aitken JF; Zhang S; Buchanan CM; Hickey A; Brittain T; Cooper GJ; Loomes KM
Biochem J; 2010 Nov; 432(1):113-21. PubMed ID: 20735358
[TBL] [Abstract][Full Text] [Related]
11. Binding of a small molecule at a protein-protein interface regulates the chaperone activity of hsp70-hsp40.
Wisén S; Bertelsen EB; Thompson AD; Patury S; Ung P; Chang L; Evans CG; Walter GM; Wipf P; Carlson HA; Brodsky JL; Zuiderweg ER; Gestwicki JE
ACS Chem Biol; 2010 Jun; 5(6):611-22. PubMed ID: 20481474
[TBL] [Abstract][Full Text] [Related]
12. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones.
Qiu XB; Shao YM; Miao S; Wang L
Cell Mol Life Sci; 2006 Nov; 63(22):2560-70. PubMed ID: 16952052
[TBL] [Abstract][Full Text] [Related]
13. Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.
Lo Bianco C; Shorter J; Régulier E; Lashuel H; Iwatsubo T; Lindquist S; Aebischer P
J Clin Invest; 2008 Sep; 118(9):3087-97. PubMed ID: 18704197
[TBL] [Abstract][Full Text] [Related]
14. Recognizability of heterologous co-chaperones with Streptococcus intermedius DnaK and Escherichia coli DnaK.
Tomoyasu T; Tsuruno K; Tanatsugu R; Miyazaki A; Kondo H; Tabata A; Whiley RA; Sonomoto K; Nagamune H
Microbiol Immunol; 2018 Nov; 62(11):681-693. PubMed ID: 30239035
[TBL] [Abstract][Full Text] [Related]
15. Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.
Gao X; Carroni M; Nussbaum-Krammer C; Mogk A; Nillegoda NB; Szlachcic A; Guilbride DL; Saibil HR; Mayer MP; Bukau B
Mol Cell; 2015 Sep; 59(5):781-93. PubMed ID: 26300264
[TBL] [Abstract][Full Text] [Related]
16. Tandem repeats of highly bioluminescent NanoLuc are refolded noncanonically by the Hsp70 machinery.
Apostolidou D; Zhang P; Pandya D; Bock K; Liu Q; Yang W; Marszalek PE
Protein Sci; 2024 Feb; 33(2):e4895. PubMed ID: 38284490
[TBL] [Abstract][Full Text] [Related]
17. Molecular dissection of amyloid disaggregation by human HSP70.
Wentink AS; Nillegoda NB; Feufel J; Ubartaitė G; Schneider CP; De Los Rios P; Hennig J; Barducci A; Bukau B
Nature; 2020 Nov; 587(7834):483-488. PubMed ID: 33177717
[TBL] [Abstract][Full Text] [Related]
18. Protein folding rates and thermodynamic stability are key determinants for interaction with the Hsp70 chaperone system.
Sekhar A; Lam HN; Cavagnero S
Protein Sci; 2012 Oct; 21(10):1489-502. PubMed ID: 22886941
[TBL] [Abstract][Full Text] [Related]
19. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
[TBL] [Abstract][Full Text] [Related]
20. Temperature-controlled activity of DnaK-DnaJ-GrpE chaperones: protein-folding arrest and recovery during and after heat shock depends on the substrate protein and the GrpE concentration.
Diamant S; Goloubinoff P
Biochemistry; 1998 Jul; 37(27):9688-94. PubMed ID: 9657681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
